I Ketut Mariadi

7PUBLICATIONS
13CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 29, 2026
Microbial Composition Study in Cholangiocarcinoma: Stage-Specific Diversity Analysis in Bile and Tumor Microbiome.

|Apr 07, 2026
A Network Meta-Analysis Comparing the Efficacy of Lenvatinib, Atezolizumab plus Bevacizumab, and Sorafenib in the Treatment of Unresectable Hepatocellular Carcinoma.

Ni Putu Sri Indrani Remitha, I Gede Aswin Parisya Sasmana, I Komang Wira Ananta Kusuma

|Nov 28, 2025
Prognostic Significance of Up-to-Seven Criteria Versus Milan Criteria for Hepatocellular Carcinoma Patients Undergoing Resection or Locoregional Therapy: A Systematic Review and Meta-Analysis.

Ni Putu Sri Indrani Remitha, I Komang Wira Ananta Kusuma, I Gede Aswin Parisya Sasmana

|Aug 24, 2025
Gene Expression Profiling of Advanced Stage Hepatocellular Carcinoma: A Bioinformatic Analysis.

Ajib Zaim Alamsyah, Putu Enrico Pramana Okaniawan, Kadek Mercu Narapati Pamungkas

|Jun 21, 2025
Efficacy of Lenvatinib Versus Sorafenib in the Treatment of Unresectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Ni Putu Sri Indrani Remitha, Ni Putu Rista Pradnya Dewi, I Komang Chandra Yogananda

|May 29, 2025
Efficacy and Safety of Lenvatinib versus Atezolizumab Plus Bevacizumab in the Treatment of Unresectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Ni Putu Sri Indrani Remitha, Ni Putu Rista Pradnya Dewi, I Komang Wira Ananta Kusuma

Pageof 2

Frequent Collaborators

7 joint publications

Dwijo Anargha Sindhughosa

4 joint publications

Ni Putu Sri Indrani Remitha

3 joint publications

I Gede Putu Supadmanaba

2 joint publications

Ajib Zaim Alamsyah